联合原代 CAR NK 细胞与放疗精准靶向横纹肌肉瘤
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.
69.3分
★★★☆☆
站内排序·非疗效
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.
Single-cell imaging of T cell immunotherapy responses in vivo.
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma.
MEMBER ACCOUNT
登录成功会直接打开下一页。